Trial NCT04171843

View at ClinicalTrials.gov 
Org. Study IDs: PBCAR269A-01

Last trial update was posted on 2023-09-21

MeSH Interventions

Cyclophosphamide Fludarabine Nirogacestat

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Relapsed/Refractory Multiple Myeloma

Stopping Reasons

Study was terminated due to lack of sufficient therapeutic effect

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID